Vir Biotechnology - 在交易完成时将收到5500万欧元的初始补偿款,并将获得4.95亿欧元的临床、监管及销售里程碑款项
Vir Biotechnology - 在交易完成时将收到5500万欧元的初始补偿款,并将获得4.95亿欧元的临床、监管及销售里程碑款项
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.